SLGL

Sol-Gel Technologies Ltd. (SLGL) | Rumor.io

Sol-Gel Technologies

SLGL

Attention (50-day avg)0%

Attention rank (50-day avg)#1,382

Bullish sentiment (50-day avg)100%

Price to earnings ratio-31.9

Market capitalization227.4M

Earnings per share-5.62

Dividend yield (TTM)—

Revenue (annual)19.4M

Net income (annual)-6.1M

Social

What share of all stock conversation is about SLGL?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 24

Sol-Gel Technologies Ltd. (SLGL) has seen significant institutional buying pressure following its oversubscribed offering, leading to a technical breakout.
The company's margin expansion story has attracted strong demand, with SLGL surging to $87.57 (+32.28%) and confirming the high-conviction technical breakout.
SLGL has priced a $33.1 million share offering at $72 each, with the oversubscribed offering indicating strong institutional demand for the company's shares.

Generated by AI

Sentiment

Of the messages about SLGL that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.67% +0.48
Bearish	—	—	—	3.33% -0.48

Bullish· Mar 24

Sol-Gel Technologies Ltd. (SLGL) has seen significant institutional buying pressure, with a major government contract secured and a high-conviction technical breakout.
The company's oversubscribed offering has confirmed strong institutional demand, with a price increase of 32.28% and a 30.44% surge in share price.
The institutional conviction in SLGL's accelerating profit growth, fueled by the oversubscribed offering and a fast-tracked regulatory catalyst, has created a high-conviction momentum play.

Bearish· Jul 26

The ask is thin up to $0.75, indicating a lack of buyers.
Retail shorts are running out of ammo and may be unable to continue shorting the stock.
The stock's volume is extremely low, with only 600 trades in the last 4 minutes, which may be artificially propping up the price.

Generated by AI

Topics

Of the messages about SLGL that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	30%	6.53%
Technical Analysis	—	—	0%	27.97%
Analysts	—	—	70%	33.18%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.05%
Macro	—	—	0%	32.27%

Analysts· Dec 31

JMP Securities analyst Donald Ellis raised the price target on Sol-Gel Technologies Ltd. to $33.00 after Twyneo demonstrated statistically significant efficacy in Ph.3 studies.
Jefferies and H.C. Wainwright both raised the price target on Sol-Gel Technologies Ltd. to $24.00 and $26.00, respectively, while maintaining a buy rating.
JMP Securities and Jefferies Financial Group raised the price target on Sol-Gel Technologies Ltd. to $33.00 and $24.00, respectively, while maintaining an outperform and buy rating, respectively.

Announcements· Mar 24

Sol-Gel Technologies Ltd. (SLGL) has announced an oversubscribed offering priced at $72.00 per share, raising approximately $33.06 million.
The offering is expected to provide strategic capital for the company's margin expansion story and pipeline funding, with significant volume spikes anticipated due to capital infusion.
The oversubscribed offering has catalyzed a strong institutional demand for SLGL, with the stock surging by over 32% to $87.57, breaching key resistance levels and confirming a breakout towards a technical target of $120.39.

Technical Analysis· Mar 24

$SLGL decisively breaches the $74.11 resistance on elevated volume, with a +31.27% surge and a technical target projecting to $120.39.
The oversubscribed offering provides a fundamental catalyst for the breakout, with momentum confirmed and a strong volume surge supporting the move.
The asset's price is expected to reach $120.39, with the oversubscribed offering fueling momentum and the structure of the move indicating a powerful trend.

Generated by AI

Community

Of the messages about SLGL, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	33.59%
Newcomers	—	—	100%	66.41%

Regulars· Apr 27

Sol-Gel Technologies Ltd. has filed a recent Form 6-K with the SEC, which may be related to foreign issuer reporting.
The stock price of SLGL has declined by 11.9% in recent trading, with some price action observed in premarket trading.
Sol-Gel Technologies Ltd. has announced an update regarding the U.S. FDA approval process for EPSOLAY 5%, a key development for the company.

Newcomers· Mar 24

The company Sol-Gel Technologies Ltd. ($SLGL) has seen significant insider buying, with Opaleye Management Inc. purchasing 39,665 shares for $2.9M at $72.00/share.
Institutional buying pressure is building for $SLGL, following the oversubscribed offering, which is signaling a potential technical breakout.
$SLGL's oversubscribed offering has confirmed strong institutional demand for the company's margin expansion story, with the stock surging to $87.57 (+32.28%).

Generated by AI

SolGel Technologies (SLGL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

12d agoYahoo Finance

Sol Gel Tech earnings beat by $2.20, revenue fell short of estimates

1mo agoInvesting.com

H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target

2mo agoInvesting.com

Also Discussed

Investors talking about SLGL also mention

#	Name	Attention
1	MediWound Ltd.MDWD	0%0
2	EUDA Health Holdings LimitedEUDA	0%new
3	60 Degrees Pharmaceuticals Inc.SXTP	0%+0
4	MKDWELL Tech Inc.MKDW	0%+0
5	Protalix BioTherapeutics, Inc.PLX	0%+0
6	Zentalis Pharmaceuticals, Inc.ZNTL	0%new
7	LanzaTech Global Inc. Common StockLNZA	0%new
8	Distribution Solutions Group, Inc.DSGR	0%0
9	LMNL - Liminal BioSciences Inc.	——
10	Ardelyx IncARDX	0.01%+0.01

Sol-Gel Technologies Ltd.

Healthcare
Biotechnology

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing and commercializing topical treatments for skin diseases. Its current portfolio includes approved products for acne vulgaris and papulopustular rosacea, alongside a pipeline of dermatology candidates aimed at severe and rare skin conditions such as Gorlin syndrome and other hyperkeratosis-related disorders. The company also works on generic topical drug products and uses its proprietary silica-based microencapsulation technology to improve the stability, tolerability, and delivery of active ingredients. Sol-Gel Technologies Ltd. serves healthcare markets in Israel and internationally, with its products and development programs positioned within medical dermatology and specialty pharmaceuticals. Founded in 1997 and headquartered in Ness Ziona, Israel, the company operates as a focused participant in the treatment of skin disorders through targeted topical therapies.

Website

Location

7 Golda Meir Street

Ness Ziona, 7403650

Israel

Social

What share of all stock conversation is about SLGL?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 24

Sol-Gel Technologies Ltd. (SLGL) has seen significant institutional buying pressure following its oversubscribed offering, leading to a technical breakout.
The company's margin expansion story has attracted strong demand, with SLGL surging to $87.57 (+32.28%) and confirming the high-conviction technical breakout.
SLGL has priced a $33.1 million share offering at $72 each, with the oversubscribed offering indicating strong institutional demand for the company's shares.

Generated by AI

Sentiment

Of the messages about SLGL that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.67% +0.48
Bearish	—	—	—	3.33% -0.48

Bullish· Mar 24

Sol-Gel Technologies Ltd. (SLGL) has seen significant institutional buying pressure, with a major government contract secured and a high-conviction technical breakout.
The company's oversubscribed offering has confirmed strong institutional demand, with a price increase of 32.28% and a 30.44% surge in share price.
The institutional conviction in SLGL's accelerating profit growth, fueled by the oversubscribed offering and a fast-tracked regulatory catalyst, has created a high-conviction momentum play.

Bearish· Jul 26

The ask is thin up to $0.75, indicating a lack of buyers.
Retail shorts are running out of ammo and may be unable to continue shorting the stock.
The stock's volume is extremely low, with only 600 trades in the last 4 minutes, which may be artificially propping up the price.

Generated by AI

Topics

Of the messages about SLGL that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	30%	6.53%
Technical Analysis	—	—	0%	27.97%
Analysts	—	—	70%	33.18%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.05%
Macro	—	—	0%	32.27%

Analysts· Dec 31

JMP Securities analyst Donald Ellis raised the price target on Sol-Gel Technologies Ltd. to $33.00 after Twyneo demonstrated statistically significant efficacy in Ph.3 studies.
Jefferies and H.C. Wainwright both raised the price target on Sol-Gel Technologies Ltd. to $24.00 and $26.00, respectively, while maintaining a buy rating.
JMP Securities and Jefferies Financial Group raised the price target on Sol-Gel Technologies Ltd. to $33.00 and $24.00, respectively, while maintaining an outperform and buy rating, respectively.

Announcements· Mar 24

Sol-Gel Technologies Ltd. (SLGL) has announced an oversubscribed offering priced at $72.00 per share, raising approximately $33.06 million.
The offering is expected to provide strategic capital for the company's margin expansion story and pipeline funding, with significant volume spikes anticipated due to capital infusion.
The oversubscribed offering has catalyzed a strong institutional demand for SLGL, with the stock surging by over 32% to $87.57, breaching key resistance levels and confirming a breakout towards a technical target of $120.39.

Technical Analysis· Mar 24

$SLGL decisively breaches the $74.11 resistance on elevated volume, with a +31.27% surge and a technical target projecting to $120.39.
The oversubscribed offering provides a fundamental catalyst for the breakout, with momentum confirmed and a strong volume surge supporting the move.
The asset's price is expected to reach $120.39, with the oversubscribed offering fueling momentum and the structure of the move indicating a powerful trend.

Generated by AI

Community

Of the messages about SLGL, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	33.59%
Newcomers	—	—	100%	66.41%

Regulars· Apr 27

Sol-Gel Technologies Ltd. has filed a recent Form 6-K with the SEC, which may be related to foreign issuer reporting.
The stock price of SLGL has declined by 11.9% in recent trading, with some price action observed in premarket trading.
Sol-Gel Technologies Ltd. has announced an update regarding the U.S. FDA approval process for EPSOLAY 5%, a key development for the company.

Newcomers· Mar 24

The company Sol-Gel Technologies Ltd. ($SLGL) has seen significant insider buying, with Opaleye Management Inc. purchasing 39,665 shares for $2.9M at $72.00/share.
Institutional buying pressure is building for $SLGL, following the oversubscribed offering, which is signaling a potential technical breakout.
$SLGL's oversubscribed offering has confirmed strong institutional demand for the company's margin expansion story, with the stock surging to $87.57 (+32.28%).

Generated by AI

Sol-Gel Technologies

Social

Mar 24

Sentiment

Bullish· Mar 24

Bearish· Jul 26

Topics

Analysts· Dec 31

Announcements· Mar 24

Technical Analysis· Mar 24

Community

Regulars· Apr 27

Newcomers· Mar 24

News

Sol-Gel completes phase 3 trial for Gorlin syndrome treatment

SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Sol Gel Tech earnings beat by $2.20, revenue fell short of estimates

H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target

Also Discussed

Sol-Gel Technologies Ltd.

Company Information

Location

News

Sol-Gel completes phase 3 trial for Gorlin syndrome treatment

SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Sol Gel Tech earnings beat by $2.20, revenue fell short of estimates

H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target

Also Discussed

Social

Mar 24

Sentiment

Bullish· Mar 24

Bearish· Jul 26

Topics

Analysts· Dec 31

Announcements· Mar 24

Technical Analysis· Mar 24

Community

Regulars· Apr 27

Newcomers· Mar 24